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Abstract
Background: G protein-coupled receptors (GPCRs) are major players in cell communication, regulate a whole
range of physiological functions during development and throughout adult life, are affected in numerous
pathological situations, and constitute so far the largest class of drugable targets for human diseases. The
corresponding genes are usually expressed at low levels, making accurate, genome-wide quantification of their
expression levels a challenging task using microarrays.
Results: We first draw an inventory of all endo-GPCRs encoded in the murine genome. To profile GPCRs genome-
wide accurately, sensitively, comprehensively, and cost-effectively, we designed and validated a collection of
primers that we used in quantitative RT-PCR experiments. We experimentally validated a statistical approach to
analyze genome-wide, real-time PCR data. To illustrate the usefulness of this approach, we determined the
repertoire of GPCRs expressed in cerebellar granule neurons and neuroblasts during postnatal development.
Conclusions: We identified tens of GPCRs that were not detected previously in this cell type; these GPCRs
represent novel candidate players in the development and survival of cerebellar granule neurons. The sequences of
primers used in this study are freely available to those interested in quantifying GPCR expression comprehensively.
Background
GPCRs are seven transmembrane-domain receptors that
are selectively activated by a wide array of ligands such
as hormones, neurotransmitters, metabolites, odorants,
pheromones, gustatory molecules and photons. They
constitute as much as 3-6% of the genes encoded in the
mammalian genomes [1]. Endo-GPCRs, i.e.t h o s e
GPCRs that have a demonstrated or putative endogen-
ous ligand, represent about one fourth of all GPCRs; the
remaining ones are activated by odorants, pheromones,
gustatory molecules and light. From a functional point
of view, GPCRs have a role in virtually every physiologi-
cal function [2]. It is therefore not surprising that
approximately 45% of clinically relevant molecules target
a GPCR [3]. Furthermore, ~35% of all endo-GPCRs are
orphans, i.e. they have no identified ligand, and consti-
tute an attractive reservoir of pharmacological targets.
It is of major interest to many academic and pharma/
biotech scientists to determine the repertoire of GPCRs
expressed in a given tissue or cell type, for instance to
identify novel pharmacological targets in a murine
model of a human disease. Furthermore, the remodeling
of the GPCR repertoire during the development of the
pathology in such a model may help prioritize which
GPCRs should be targeted first.
Most cells express a small number of a given GPCR
protein at their surface. Accordingly, these genes are
usually expressed at low levels [4], which makes their
accurate quantification by microarray-based detection
systems challenging. RNA deep sequencing has the
power to accurately determine expression levels of
weakly expressed genes, at the expense of costs, how-
ever. Real-time RT-PCR is reputedly more sensitive than
microarrays, but its throughput was limited until
recently. Real-time PCR machines in the 384-, 1,536-,
3,200- or 9,216-well format became recently available
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any medium, provided the original work is properly cited.and affordable. This prompted us to develop a collection
of primers that can be used in real time RT-PCR experi-
ments to characterize GPCR expression genome-wide.
We first draw an inventory of all endo-GPCRs encoded
in the murine genome. We then designed and validated
a collection of primers for quantitative RT-PCR experi-
ments, and selected adequate statistical tests. To illus-
trate the usefulness of this approach, we determined the
repertoire of GPCRs expressed in cerebellar granule
neurons and neuroblasts during postnatal development.
We identified tens of GPCRs that were not detected
previously in this cell type; these GPCRs represent novel
candidate players in the development and survival of
cerebellar granule neurons.
Results and discussion
Identification of endo-GPCRs
Our first aim was to identify endo-GPCRs encoded by the
murine genome as comprehensively as possible. We ori-
ginally started from Unigene clusters annotated as
“receptor”, and manually sorted known GPCRs and seven
transmembrane- (7TM) proteins. At that step, we
excluded 7TM receptors related to odorant and phero-
mone receptors. To discover genes encoding novel 7TM
receptors, we blasted the murine genome with the trans-
membrane domain of the 263 7TM proteins selected
from Unigene. The process was reiterated with novel
sequences not annotated as GPCR in the original Uni-
gene set until no novel sequence could be discovered.
The transcription of the sequences identified in this way
was confirmed by searching the murine EST database.
This strategy allowed us to identify 382 murine endo-
GPCRs, which are listed in Additional file 1. The number
of GPCR we identified is in line with previous studies
that used bioinformatics and/or literature mining [4-8].
A special point should be made regarding the murine
Mas-related family of GPCR (Mrgpr). As shown pre-
viously [9,10], the murine Mrg family consists of six sin-
gle-copy genes (Mrgprd, Mrgpre, Mrgprf, Mrgprg,
Mrgprh/Gpr90,a n dMas1), as well as three large subfa-
milies (Mrgpra, Mrgprb, and Mrgprc) that together com-
prise about 50 distinct sequences. Members of the
Mrgpra subfamily are poorly characterized, and many of
them are predicted sequences or gene models that have
no or very few experimental supporting data. The
Mrgprc family members are all pseudo-genes that do
not encode GPCRs [9]. As far as expression patterns are
concerned, Mrgprd and the members of the Mrgpra
family are expressed exclusively in the sensory neurons
and in the trigeminal ganglia [9]. In contrast, Mrgprb1-
5, Mas1, Mrgpre, Mrgprf, Mrgprg,a n dMrgprh/Gpr90
are not expressed in dorsal root ganglia [9]. We there-
fore decided to focus on members of the Mrgpra sub-
family that have been sufficiently characterized
(Mgrpra1-4, Mrgpra6), members of the Mrgprb subfam-
ily (Mrgprb1-5, Mrgprb10), and the six single-copy
Mrgpr. Because ambiguity could not be resolved, we did
not include in the GPCR collection 9 sequences with
homologies to the Mrgpra family and 4 sequences with
homologies to the Mrgprb family. It is therefore likely
that additional members of the Mas-related family of
GPCR do exist.
In addition to GPCRs, we also included in our analysis
7 genes encoding proteins that are not GPCR but rather
alter GPCR pharmacology and/or coupling specificity.
The Ramp1-3 (Receptor activity modifying protein)
genes encode single transmembrane proteins that physi-
cally interact with receptors for calcitonin (Calcr) and
calcitonin gene-related peptide (Calcrl). These 2 GPCRs
are activated by a range of peptides, namely calcitonin,
amylin, calcitonin gene-related peptide, adrenomedullin
and intermedin/adrenomedullin 2, depending on the
Ramp with which they interact [11]. In addition, effi-
cient signal transduction by Calcr and Calcrl requires
interaction with Crcp [12]. Knowledge about Ramp1-3
and Crcp expression is mandatory to interpret data
about Calcr and Calcrl expression. These 4 genes were
then included in the primer collection and annotated as
‘GPCR-modifiers’. For similar reasons, we designed pri-
mers aimed at quantifying transcripts encoding the 3
secreted frizzled proteins, i.e. Sfrp1, Sfrp2 and Sfrp3/Frzb
[13]. These genes are also included in Additional file 1.
Design and validation of a primer collection for real-time
PCR
Primers aimed at quantifying GPCR transcripts are
available. One collection is far from comprehensive
however, as it targets 274 GPCRs only [14]. The other
commercially available collections are not comprehen-
sive and not experimentally validated [8,15]. Further-
more, the commercial collections rely on Taqman
®
probes, which ensure high specificity, but display lower
sensitivity than SybrGreen
®-based detection systems
(see Additional file 2 for a comparison of 8 randomly
selected Taqman assays to the corresponding primers
used in this study). To be as comprehensive, sensitive,
and reliable as possible, we designed and validated pri-
mer pairs suitable for quantification of every GPCR we
identified using SybrGreen
®-based detection systems.
We focused exclusively on coding sequences, as the
identification of the open reading frame (ORF) of a pre-
viously uncharacterized GPCR transcript is greatly facili-
tated by the characteristic 7TM topology. We therefore
felt more confident in targeting the ORF region rather
than the untranslated regions, specially for gene models
and transcripts reconstructed from genomic sequences.
The validation of a primer pair requires the assessment
of the specificity and efficiency of the amplification
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ing matrix is available. Because a number of the target
GPCRs has never been studied previously, no corre-
sponding sequence cloned in a plasmid is available; nor is
available information about the pattern of the GPCR
expression, which precluded the use of cDNAs. Hence
we favored primers located in the same exon to allow the
validation of the primer pairs using genomic DNA rather
than cDNA or plasmids. This strategy is possible only if
the cDNA mix that is to be used in real experiments is
completely devoid of genomic DNA, which was routinely
achieved by treatment of the RNA samples with RNase-
free Dnase (data not shown). To validate each primer
pair we performed real-time PCR with 6 different
amounts of genomic DNA from100 pg (~50 copies of an
autosomal gene) to 20 ng (~10,000 copies). We plotted
the threshold cycle (Ct) vs. the log of the amount of
input genomic DNA, and measured the slope and the
correlation coefficient (r
2) of the resulting linear regres-
sion straight line, and the Ct for 1 ng of input genomic
DNA. We considered that a primer pair is acceptable if,
in 2 independent tests, the slope was above -3.6 (>90%
amplification efficiency), the correlation coefficient was
above 0.95 and the Ct(1 ng) was below 30.
The specificity of the amplification product was veri-
fied in each experiment by inspection of the amplicon
melting curve, which is expected to display a single peak
at a temperature close to the theoretical amplicon melt-
ing temperature. Approximately 10% of the amplicons
were loaded on an agarose gel to verify their size, and
were sequenced on both strands. The sequences of the
primers used in this study are available in the Additional
file 3.
Statistical analysis and normalization of PCR data
The next step was the selection of statistical tests suita-
ble for testing differences in the expression levels of
g e n e sa c r o s st h es a m p l e st ob ea n a l y z e d .T h el a r g e
scale, real-time PCR studies reported above either did
not perform statistics or used parametric tests to test
for differences in transcript abundance among samples.
None of these studies corrected for multiple testing,
which is obviously required given the large number of
statistical tests to be performed in a single experiment.
Parametric tests are more efficient than non-parametric
tests in detecting differences between groups of values,
but the distribution of the random variable should be
known a priori. Student’s t-test for instance assumes a
Gaussian distribution. Similarly, although ANOVA does
not call for normality, it is sensitive to heteroscedasti-
city. It was therefore important to determine if the PCR
data can be assumed to be normally distributed, and
whether the variance is dependent on initial target
abundance or not. We randomly selected 9 primer pairs
with GC-content ranging from 46 to 60% (Additional
file 4) from the GPCR collection, and performed 64
replicate PCR on 50 pg, 500 pg, and 5 ng of genomic
DNA. We plotted the distribution of the Ct values
(Additional files 5, 6, 7, 8, 9, 10, 11, 12 and 13), and
tested the normality of the distribution using a whole
range of statistical tests (Additional file 4). Surprisingly,
out of 9 primer pairs tested with 3 amounts of input
genomic DNA, 55% produced a bimodal or a non-Gaus-
sian distribution in at least one condition. Furthermore,
2/3 of the primers tested displayed a standard deviation
that increased with decreased amount of input genomic
DNA (Additional file 4), indicating heteroscedasticity.
We concluded that we cannot assume the distribution
of PCR data to be normal and homoscedastic, and we
cannot routinely use parametric tests with high through-
put PCR data. Similar experiments performed on 1 and
4 ng of cerebellar cDNAs led to the same conclusion
(data not shown). Accordingly, we analyzed the PCR
data using the Wilcoxon signed-rank and Kruskal-Wallis
tests with Benjamini-Hochberg correction for multiple
testing [16] as implemented in the non parametric mod-
ule of the MeV 4.2 package [17]. For Kruskal-Wallis
test, post-hoc tests were performed with the XLStat
software (AddinSoft).
For real experiments, 2 rounds of normalization were
routinely performed. To eliminate the plate-to-plate
PCR variability, the data were normalized using the geo-
metric average of ‘house keeping’ genes expression levels
in a way similar to the one proposed by Vandesompele
and co-workers [18]. However, in contrast to the setting
by Vandesompele and co-workers, each PCR plate com-
prised a single cDNA sample and primer pairs for multi-
ple genes, including the selected reference genes. The
level of expression of each GPCR “X” was normalized to
the geometric mean of the expression levels of the
selected reference genes, R1 to R3, in the same PCR
plate according to the formula:
X
3 √
R1xR2R3 =2
Ct(X)−
Ct(R1) + Ct(R2) + Ct(R3)
3 .
The MeV 4.2 package [17] was used for further pro-
cessing and analysis of the data. To reduce the variabil-
ity introduced by reverse transcription (RT), the
normalized, log2-transformed PCR data obtained from
individual RT were mean-centered and scaled in SD
units.
GPCR regulation during apoptosis of cerebellar granule
cells
In the nervous system, GPCRs are critically involved
during the embryonic development. For instance, Sonic
Hedgehog (Shh) and Frizzled (Fz) are critical players in
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GPCRs, i.e. Smoothened (Smo) and Wnt family mem-
bers, respectively. In the adult brain, GPCRs are key
modulators of synaptic activity. Accordingly, they are
targeted by most psycho-active molecules.
To illustrate the usefulness of the high throughput
PCR approach, we and others performed tissue profiling,
which gives a static view of the GPCR repertoire in a
mixture of cell types [8,19]. In the present work, we
focused on a more dynamic setting, and monitored the
remodeling of the GPCR repertoire in a single neuronal
subtype. We used a cellular model of neuronal develop-
ment that was previously studied in the laboratory
[20,21], and which is highly appropriate for population-
based studies using techniques such as microarrays and
PCR. Cerebellar granule neurons (CGNs) constitute the
most abundant neuronal population in the mammalian
central nervous system, and can be cultured in vitro up
to 98% homogeneity. Cerebella were collected at P7,
which corresponds to the very ending of the granule
neuroblast expansion period in vivo. The neuroblasts
complete their last division approximately 1 day after
plating, and exit the cell cycle to enter differentiation in
a synchronous process. After 7 days in culture, the
CGNs are fully differentiated and functional. The whole
culture process takes place in the presence of depolariz-
ing concentrations of potassium chloride ([KCl] = 25
mM; K25) that induce a phasic electrical activity. Depo-
larization is presumed to mimic the endogenous excita-
tory activity that is required for CGN survival during
cerebellar development in vivo (Ikonomidou et al.,
1999). Lowering [KCl] to 5 mM (K5) in the absence of
serum triggers apoptosis [22]. This mimics the naturally
occurring death that takes place in the external granular
layer of newborn rodent cerebellum [23]. This apoptosis
process is fully dependent on new RNA and proteins
synthesis [22], and we previously identified genes regu-
lated early after CGN apoptosis induction using micro-
arrays [20]. Although a role for GPCR activation in
preventing potassium withdrawal-induced apoptosis of
CGNs is abundantly documented, we observed the regu-
lation of a very limited number of genes encoding
GPCRs in our previous microarray-based study. One
reason might be that the regulation of GPCR activity
during the apoptotic process does not involve gene reg-
ulation. An alternative explanation is the reputed lack of
sensitivity of microarrays, which prompted us to use the
v e r ys a m es a m p l e sa st h o s eu s e di no u rp r e v i o u ss t u d y
[20] to monitor GPCR expression in K25- vs. K5-treated
CGN cultures.
We first draw the distribution of GPCR expression
levels in K25 culture (Figure 1). We observed 3 popu-
lations of GPCRs. The vast majority of GPCRs (298)
were expressed at very low levels (< median + 3.5
interquartile (IQR) range).I nc o n t r a s t ,3 8G P C R sw e r e
abundantly expressed, i.e. >median + 10.5 IQR. A third
population of GPCRs (46) displayed intermediate
expression levels. With the notable exception of Mc5r
that belongs to this intermediate population, those
GPCRs that were shown to be differentially expressed
(DE) using microarrays [20], i.e. Sstr2, Chrm3, Gpr125,
Gpr123, Fzd8 and Adcyp1r1, were all among the most
abundantly expressed GPCRs. These genes were also
found as DE genes using the Wilcoxon signed-rank
test with Benjamini-Hochberg correction on our qPCR
data (Figure 2). In addition, we identified tens of DE
GPCRs that were not identified using microarrays
(Additional file 14). As shown on the MA plot dis-
played on Figure 2, most of the DE GPCRs with large
fold-changes correspond to weakly expressed GPCRs.
In contrast those DE GPCRs that were abundantly
expressed displayed lower fold-changes. This confirms
that the qPCR approach is more sensitive and has a
larger dynamic range in fold-change than the microar-
ray-based approach.
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Figure 1 Distribution of the abundance of transcripts encoding
G protein-coupled receptors in differentiated cerebellar
granule neurons. Transcripts encoding 382 GPCRs were quantified
in cerebellar granule neurons grown in vitro for 7 days (DIV 7) using
real-time PCR. The distribution of transcript abundance was plotted
with intervals equal to the interquartile range (IQR; the difference
between the first and third quartile). The majority (298) of GPCRs
are expressed at very low levels, i.e. between median - 0.5 IQR and
median + 3.5 IQR. A population of 46 GPCRs displays intermediate
expression levels (median + 4.5 IQR to median + 9.5 IQR), and 38
GPCRs are expressed above median + 10 IQR. The medium to high
population of GPCRs likely corresponds to the physiologically most
relevant GPCRs.
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previously shown to result in anti-apoptotic activity in
this model, e.g. Adcyap1r1 [24], Gabbr2 [25]..., were
found DE using the qPCR approach. As the CGNs were
collected as early as 4 hours after potassium withdrawal,
i.e. far before the first biochemical and morphological
stigmata of apoptosis were discernible, it is likely that
CGNs attempt to counteract the pro-apoptotic insult in
part by up-regulating GPCRs whose activity is poten-
tially beneficial, provided the cognate ligand is present
in the extracellular milieu.
GPCR regulation during post-natal development of
cerebellar granule cells
Because of its stereotyped organization, the development
of the cerebellum has been extensively studied [26]. The
migration, proliferation, survival and differentiation of
mouse cerebellar granule cells is controlled by a com-
plex array of transcription factors and signaling path-
ways [27]. Direct GPCR ligands and modulators of
GPCR activity, e.g.S h h ,t h eW n tp r o t e i n sa n dC x c l 1 2 /
Sdf1, were shown to control different aspects of cerebel-
lar granule differentiation, survival and positioning.
However, the role of the majority of GPCRs expressed
by cerebellar granule neuroblasts and neurons remains
largely undefined.
We used the same in vitro culture model to monitor
the repertoire of GPCRs expressed by cerebellar neuro-
blasts and during the postnatal differentiation and
maturation of CGNs. Additional file 15 shows those
GPCRs that were detectable in at least one condition, i.
e. displayed Ct below 30 in at least 3 out of 15 PCR
reactions. Not surprisingly, we found a number of
GPCRs that were previously shown to influence various
aspects of the CGN developmental process such as pro-
liferation, migration, cell adhesion, survival and matura-
tion. Smoothened (Smo)e n c o d e saG P C Rt h a ti n t e r a c t s
with the Shh receptor Ptch1, and mediates the prolifera-
tive action of Shh on neuroblasts [28]. Smo was highly
expressed at day 0 when the proliferating neuroblasts
were collected, and its expression decreased when the
neuroblasts exited the cell cycle from day 1 on. Simi-
larly, the most abundantly expressed GPCR at culture
inception was Gpr56, that encodes an orphan GPCR
controlling neuroblast adhesion [29]. Cxcr4 encodes the
receptor for Cxcl12/Sdf1 (Stromal cell derived factor 1),
and was shown to be essential for neuronal cell migra-
tion and patterning in the cerebellum [30]. We also
found high expression of those GPCRs that are markers
of mature CGNs because they are involved in the con-
trol of the electrical activity of these neurons, i.e.m e t a -
botropic GABA and Glutamate receptors. In addition,
we identified tens of GPCRs that were not previously
shown to be expressed in CGNs (Additional file 15) and
are candidate players in the development and survival of
CGNs.
Among expressed GPCRs, we sought to identify those
that were regulated during the developmental time
course as this may be an indication of a specific role for
these GPCRs during CGN differentiation A Kruskal-
Wallis test with Benjamini-Hochberg correction identi-
fied those GPCRs differentially expressed in at least one
condition. DE GPCRs classification using a hierarchical
clustering algorithm [17] revealed that a large number
of GPCRs are very dynamically regulated during CGN
development (Figure 3), suggesting that CG neuroblasts
and mature neurons are sensitive to, at least in part, dif-
ferent sets of extracellular cues.
We then sought to determine if the remodeling of the
GPCR repertoire is continuous throughout the develop-
mental process or whether there is a specific period at
which remodeling is more active, and the GPCR reper-
toire becomes fixed. We first ranked the GPCRs accord-
ing to their expression levels at each time point. We
then calculated for each GPCR the absolute rank differ-
ence between 2 consecutive time points. The more
remodeling of the GPCR repertoire, the higher the
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Figure 2 MA plot of the expression levels of G protein-coupled
receptors differentially expressed between healthy and early
apoptotic cerebellar granule neurons. Mouse cerebellar granule
neurons grown in vitro for 7 days (DIV 7) were incubated for 4
hours in culture medium containing 25 mM (K25) or 5 mM (K5) KCl
without serum. GPCR expression levels were determined using real-
time PCR, and differentially expressed GPCRs were identified using
the Wilcoxon signed-rank test with Benjamini-Hochberg correction.
M is the log2-transformed ratio of the normalized expression levels
of each GPCR in K5 and K25. A is the log2-transformed maximum of
the normalized expression levels of each GPCR in K5 and K25. Red
dots indicate those GPCRs that were also identified as differentially
expressed in our previous microarray study [20] using the very same
RNA samples. The real-time PCR approach identified more DE
GPCRs than microarrays, especially among GPCRs expressed at low
to medium levels.
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points. We then compared the distribution of the rank
difference for the whole GPCR set (Figure 4A) and for
the 50 most abundantly expressed GPCRs at DIV 9 (Fig-
ure 4B). For the whole GPCR set, the average rank var-
iation is similar at each time point (Figure 4A). This is
due to the fact that the ranks of the majority of weakly
expressed GPCRs vary more or less randomly as their
expression is biologically not significant. In contrast,
when only the 50 most abundantly expressed GPCRs
are considered, the distributions display a decrease in
the average difference between 2 consecutive time
points, before and after DIV 3 (Figure 4B). This indi-
cates that the repertoire of GPCRs expressed by mature,
DIV9 CGNs is largely determinate at DIV3. Interest-
ingly, DIV3 CGNs do not display morphological and
functional features of mature CGNs such as extended
neurites, synaptic connections and electrical activity.
Hence, the remodeling of the GPCR repertoire precedes
neurite outgrowth, establishment of synaptic connec-
tions or electrical activity. Similarly, it does not depend
on environmental and positional cues, which are
obviously disrupted or abolished in the in vitro culture
system. We concluded that the remodeling of the GPCR
repertoire that occurs during postnatal CGN develop-
ment is a robust, inbuilt process characteristic of CG
neuroblasts exiting the cell cycle.
Conclusions
This work identified the complete repertoire of GPCR
encoded by the murine genome. Based on this informa-
tion, we designed and validated a collection of primer
pairs that allows the specific and sensitive quantification
of GPCR transcripts using real-time PCR. We showed
that non parametric statistical tests should be used rou-
tinely to identify variations of GPCR transcript abun-
dance. Finally, we used this tool to characterize the
repertoire of GPCRs expressed in cerebellar granule
neurons, the most abundant central nervous system
neuronal population. We showed that remodeling of the
GPCR repertoire is an early event following cell cycle
withdrawal of cerebellar neuroblasts, which is indepen-
dent of environmental cues, neurite outgrowth and
synaptic connections. This work paves the way towards
the systematic identification of GPCRs expressed and
regulated in murine models of human pathologies, offer-
ing the potential to identify novel, drugable pharmacolo-
gical targets for these pathologies.
Methods
in vitro culture of mouse cerebellar granule neuroblasts
Design of the animal research was approved by the
Institut de Génomique Fonctionnelle’s ethics committee.
CGN cultures were prepared from 7-day-old murine
Figure 3 Hierarchical clustering of G protein-coupled receptors
differentially expressed during the development of cerebellar
granule neuroblasts in vitro. Transcripts encoding 382 GPCRs were
quantified using real-time PCR throughout the developmental
process that leads from cerebellar granule neuroblasts to mature
neurons in vitro. Data represent the average of 3 independent
reverse transcription and PCR experiments. To take into account
technical variations, the level of expression of each GPCR was
normalized to the geometric mean of the expression levels of 3
selected reference genes, i.e. B2m, Gapdh, and Gusb. A Kruskal-Wallis
test with Benjamini-Hochberg correction identified those GPCRs
differentially expressed (DE) at one time point at least. Each GPCR
was then expressed as the percentage of the maximal expression
levels of that GPCR during the time course. DE GPCRs were
classified according to their expression pattern using a hierarchical
clustering algorithm as implemented in MeV 4.2.
Maurel et al. BMC Genomics 2011, 12:241
http://www.biomedcentral.com/1471-2164/12/241
Page 6 of 9pups (C57BL/6J mice, Charles River Laboratories) as
described by Miller and Johnson [31] with slight modifi-
cations. Briefly, freshly dissected cerebella were incu-
bated for 10 min at 37°C with 0.25 mg/ml trypsin and
cells were dissociated in HBSS -Ca2+ -Mg2+ in the
presence of 0.5 mg/ml trypsin inhibitor and 0.1 mg/ml
DNaseI by several steps of mechanical disruption. The
resulting cell suspension was centrifuged and resus-
pended in K25+S medium (Basal Medium Eagle [BME]
supplemented with 10% fetal bovine serum, 2 mM L-
glutamine, 10 mM HEPES, penicillin-streptomycin 100
IU/ml-100 μg/ml and 20 mM KCl to achieve a final
concentration of 25 mM). The cell suspension was fil-
tered through a 40 μm cell strainer (Falcon) and plated
in a coated dish for 25 min to allow attachment of non-
neuronal cells. Neurons were then resuspended, counted
and seeded at a density of 25.10
4 cells/cm
2 in culture
dishes coated with poly-D-lysine (Becton Dickinson
Biosciences). The granule neurons were cultured at 37°C
in a humidified incubator with 6% CO2 /94% air for 7
days. To prevent proliferation of remaining non-neuro-
nal cells, 10 μM cytosine b-D-arabinofuranoside (Ara-C)
was added to the culture medium 24 h after plating. At
7 days in vitro, granule neurons represented more than
98% of cultured cells (data not shown).
CGN were washed and incubated for the indicated
times in serum-free BME supplemented with L-Gln,
HEPES, antibiotics and 1 μMo ft h eN M D Aa n t a g o n i s t
(+)-MK-801, and containing either 25 mM KCl (K25
medium) or 5 mM KCl (K5 medium). We chose to use
K25 medium as a control instead of initial culture med-
ium to exclude gene expression differences resulting
from serum deprivation, which has been shown to
induce the death of a small proportion of cultured CGN
[31]. Moreover, we added 1 μM of MK-801 in both K25
and K5 media to avoid any change in gene expression
due to non-controlled NMDA receptor stimulation by
endogenously released glutamate.
RNA preparation, reverse transcription and real-time PCR
Total RNA was prepared using Trizol (Invitrogen)
according to the manufacturer’s instruction. Purified
RNA was treated with the DNase I from the DNA-
free™ kit (Ambion) according to manufacturer’s
instructions. For reverse transcription, 2 μgo ft o t a l
RNA were reverse transcribed using 200 U M-MLV
reverse transcriptase (Invitrogen) in the presence of 2.5
μM random hexamers and 0.5 mM dNTP. Three inde-
pendent RT reactions were performed from each RNA
preparation. Four ng of the resulting cDNAs were used
as template for real time PCR using ABI Prism 7000
with the SybrGreen
® PCR Master Mix (Applied Biosys-
tems). Primers were designed with Primer Express™
software (Applied Biosystems). The sequences of all the
primers used were deposited in the Gene Expression
Omnibus (GEO) repository under the accession number
GPL7701. The PCR reaction was performed in 10 μli n
the presence of 300 nM specific primers. Thermal
cycling parameters were 2 min at 50 °C, 10 min at 95°C,
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Figure 4 The repertoire of GPCRs expressed by mature
cerebellar granule neurons is mostly determinate after 3 days
in vitro (DIV 3). To monitor global changes in GPCR expression,
GPCRs were ranked by their expression levels, and the absolute
difference in the ranks of each GPCR between 2 consecutive time
points, i.e. DIV 0-1, DIV 1-2, DIV 2-3 and so on, were recorded. Box
plots were drawn to visualize the distributions of the differences in
GPCR expression levels between 2 consecutive DIV. Box plots are
shown for both the whole GPCR set (Figure 4A) and for the 50
most abundantly expressed GPCRs at DIV 9 (Figure 4B). Whereas the
distributions are comparable for the whole GPCR set, the box plots
for the 50 most expressed GPCRs display a decrease in the average
difference between 2 consecutive DIV before and after DIV 3,
indicating that the repertoire of GPCRs expressed by mature
cerebellar granule neurons is mostly determinate at DIV 3, when
neurons are not morphologically mature yet.
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Page 7 of 9followed by 40 cycles of 95°C for 15 s and 60°C for 1
min. Data were analyzed with ABI prism 7000 SDS soft-
ware. The level of expression of each GPCR “X” was
normalized to the geometric mean of the expression
levels of the selected reference genes, R1 to R3, in the
same PCR plate according to the formula:
X
3 √
R1xR2R3 =2
Ct(X)−
Ct(R1) + Ct(R2) + Ct(R3)
3 .
Reference genes were selected according to the GeN-
orm procedure [18]. Reference genes used in this study
were B2m (beta-2 microglobulin), Gapdh (glyceralde-
hyde-3-phosphate dehydrogenase), and Gusb (glucuroni-
dase, beta).
Statistical analysis of PCR data
To reduce the variability introduced by reverse tran-
scription (RT), the normalized, log2-transformed PCR
data obtained from individual RT were mean-centered
and scaled in SD units. Statistical tests were performed
with the statistical module of MeV 4.2 [17]. For Krus-
kal-Wallis test, post-hoc tests were performed with
XLStat (Addinsoft). All p-value were corrected for mul-
tiple testing according to the method proposed by
Hochberg and Benjamini [16].
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